304 related articles for article (PubMed ID: 7970709)
61. Altered transcriptional activity of c-fos promoter plasmids in v-raf-transformed NIH 3T3 cells.
Siegfried Z; Ziff EB
Mol Cell Biol; 1990 Nov; 10(11):6073-8. PubMed ID: 2122238
[TBL] [Abstract][Full Text] [Related]
62. Invasiveness and chemotactic activity of oncogene transformed NIH/3T3 cells.
Melchiori A; Carlone S; Allavena G; Aresu O; Parodi S; Aaronson SA; Albini A
Anticancer Res; 1990; 10(1):37-44. PubMed ID: 2334141
[TBL] [Abstract][Full Text] [Related]
63. Possible involvement of MSX-2 homeoprotein in v-ras-induced transformation.
Takahashi C; Akiyama N; Kitayama H; Takai S; Noda M
Leukemia; 1997 Apr; 11 Suppl 3():340-3. PubMed ID: 9209384
[TBL] [Abstract][Full Text] [Related]
64. Antigens expressed on NIH 3T3 cells following transformation with DNA from human pancreatic tumor.
Hollingsworth MA; Rebellato LM; Moore JW; Finn OJ; Metzgar RS
Cancer Res; 1986 May; 46(5):2482-7. PubMed ID: 3697988
[TBL] [Abstract][Full Text] [Related]
65. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes.
McCarthy SA; Samuels ML; Pritchard CA; Abraham JA; McMahon M
Genes Dev; 1995 Aug; 9(16):1953-64. PubMed ID: 7649477
[TBL] [Abstract][Full Text] [Related]
66. Establishment of rat endometrial cell lines by retroviral mediated transfer of immortalizing and transforming oncogenes.
Wiehle RD; Helftenbein G; Land H; Neumann K; Beato M
Oncogene; 1990 Jun; 5(6):787-94. PubMed ID: 1694289
[TBL] [Abstract][Full Text] [Related]
67. Tumorigenic effects mediated in the avian embryo by one or more oncogenes associated with v-myc.
al Moustafa AE; Quatannens B; Dieterlen-Lièvre F; Saule S
Oncogene; 1992 Aug; 7(8):1667-70. PubMed ID: 1630827
[TBL] [Abstract][Full Text] [Related]
68. Transformation of human mammary epithelial cells by oncogenic retroviruses.
Clark R; Stampfer MR; Milley R; O'Rourke E; Walen KH; Kriegler M; Kopplin J; McCormick F
Cancer Res; 1988 Aug; 48(16):4689-94. PubMed ID: 3293776
[TBL] [Abstract][Full Text] [Related]
69. Rapid, complete and reversible transformation by v-sis precedes irreversible transformation.
Mercola D; Carpenter PM; Grover-Bardwick A; Mercola M
Oncogene; 1992 Sep; 7(9):1793-803. PubMed ID: 1501889
[TBL] [Abstract][Full Text] [Related]
70. [Analysis of c-onc genes in choriocarcinoma cells].
Fujino T
Hokkaido Igaku Zasshi; 1987 Sep; 62(5):798-807. PubMed ID: 3692432
[TBL] [Abstract][Full Text] [Related]
71. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
Fukasawa K; Vande Woude GF
Mol Cell Biol; 1997 Jan; 17(1):506-18. PubMed ID: 8972231
[TBL] [Abstract][Full Text] [Related]
72. Erythroproliferation in vitro can be induced by abl, fes, src, ras, bas, raf, raf/myc, erb B and cbl oncogenes but not by myc, myb and fos.
Klinken SP
Oncogene Res; 1988 Sep; 3(2):187-92. PubMed ID: 3226726
[TBL] [Abstract][Full Text] [Related]
73. The v-mos and c-Ha-ras oncoproteins exert similar effects on the pattern of protein synthesis.
Klemenz R; Hoffmann S; Jaggi R; Werenskiold AK
Oncogene; 1989 Jun; 4(6):799-803. PubMed ID: 2525241
[TBL] [Abstract][Full Text] [Related]
74. Effect of oncogene transfection or passage in vivo on malignant phenotypes of rat2 cells.
Van Roy FM; Coopman P; Suffys P; Liebaut G; Vleminckx K; Gao J; Dragonetti CH; Fiers W; Mareel MM
Anticancer Res; 1989; 9(6):1553-64. PubMed ID: 2697182
[TBL] [Abstract][Full Text] [Related]
75. Constitutive expression of FosB and its short form, FosB/SF, induces malignant cell transformation in rat-1A cells.
Kovary K; Rizzo CA; Ryseck RP; Noguchi T; Raynoschek C; Pelosin JM; Bravo R
New Biol; 1991 Sep; 3(9):870-9. PubMed ID: 1931831
[TBL] [Abstract][Full Text] [Related]
76. Potential multiple functions of the v-myc oncogene within a single cell clone of OK10 retrovirus-transformed quail fibroblasts.
Ohlsson RI; Schwarze P; Ruud E; Pfeifer-Ohlsson S
Oncogene; 1988 Oct; 3(4):457-61. PubMed ID: 3078953
[TBL] [Abstract][Full Text] [Related]
77. In vitro transformation of rat esophageal epithelial cells by fusarin C.
Lu FX; Li MX; Cheng SJ
Sci China B; 1991 Dec; 34(12):1469-77. PubMed ID: 1686973
[TBL] [Abstract][Full Text] [Related]
78. Modifications of tumor histology by point mutations in the v-fps oncogene: possible role of extracellular matrix.
Auersperg N; Pawson T; Worth A; Weinmaster G
Cancer Res; 1987 Dec; 47(23):6341-8. PubMed ID: 3315185
[TBL] [Abstract][Full Text] [Related]
79. Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice.
Schuh AC; Keating SJ; Monteclaro FS; Vogt PK; Breitman ML
Nature; 1990 Aug; 346(6286):756-60. PubMed ID: 2167455
[TBL] [Abstract][Full Text] [Related]
80. A mutant cell line derived from NIH/3T3 cells: two oncogenes required for in vitro transformation.
Katz E; Carter BJ
J Natl Cancer Inst; 1986 Oct; 77(4):909-14. PubMed ID: 3463820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
